We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MRI Fingerprint Technology Offers Early Detection of Disease

By MedImaging International staff writers
Posted on 25 Mar 2013
Magnetic resonance imaging (MRI) could routinely identify specific cancers, multiple sclerosis, heart disease, and other disorders early, when they are most treatable.

Each body tissue and disease has a unique fingerprint that can be used to diagnose problems rapidly, scientists from Case Western Reserve University (Cleveland, OH, USA) and University Hospitals (UH) Case Medical Center suggest in their article published March 2013 in the journal Nature. By using new MRI technologies to scan for different physical properties at the same time, the researches distinguished white matter from gray matter from cerebrospinal fluid (CSF) in the brain in about 12 seconds, with the promise of doing this much faster in the near future.

The technology has the potential to make an MRI scan standard procedure in annual check-ups, the authors believe. A full-body scan lasting only minutes would provide a lot more data and require no radiologist to interpret the data, making diagnostics inexpensive, compared to current scans, they argued. “The overall goal is to specifically identify individual tissues and diseases, to hopefully see things and quantify things before they become a problem,” said Dr. Mark Griswold, a radiology professor at Case Western Reserve School of Medicine and UH Case Medical Center. “But to try to get there, we’ve had to give up everything we knew about the MRI and start over.”

Magnetic resonance fingerprinting (MRF) can gather much more data with each measurement than a conventional MRI can. Dr. Griswold compares the difference in technologies to a couple of choirs. “In the traditional MRI, everyone is singing the same song and you can tell who is singing louder, who is off-pitch, who is singing softer,” he said. “But that’s about it.”

The louder, softer, and off-pitch singing is represented by dark, light, or bright spots in the scan that a radiologist must decode. An MRI scan, for instance, would reveal swelling as a bright area in an image. But brightness does not inevitably compare with cause or severity of disease. “With an MRF, we hope that with one step we can tell the severity and exactly what’s happening in that area,” remarked Dr. Griswold.

The fingerprint of each tissue, each disease, and each substance inside the body is therefore a different song. In an MRF, each member of the choir sings a different song simultaneously, Dr. Griswold stated. “What it sounds like in total is a randomized mess.”

The researchers generate distinct songs by simultaneously varying different parts of the input electromagnetic fields that probe the tissues. These variations make the received signal sensitive to four physical properties that vary from tissue to tissue. These differences—the different notes and lyrics of their songs—become evident when applying pattern recognition programs using the same math in facial recognition software.

The patterns are then mapped. Instead of looking at relative measurements from an image, Griswold said quantitative estimates told one tissue from another. As the technology progresses, these findings should determine whether tissue is healthy or diseased, how seriously and by what process. The scientists believe that they will be able to interrogate a total of eight or nine physical properties that will allow them to produce the songs from a huge range of tissues, diseases, and materials.

For a patient, an MRF would seem similar to a fast MRI. When the scan is performed, all of the patient’s songs would be compared with the songbook, which will provide physicians with a range of diagnostic data. “If colon cancer is ‘Happy Birthday’ and we don’t hear ‘Happy Birthday,’ the patient doesn’t have colon cancer,” Dr. Griswold said.

Other researchers have tried to employ multiple parameters in MRI scans, but this group was able to scan fast and with higher sensitivity than in earlier efforts, he continued. “This research gives us hope. We can see that it’s possible the MRI can see all sorts of things.”

The group expects to reduce scanning time and continue to build the library of fingerprints over the next few years. Case Western Reserve and UH Case Medical Center have a 31-year history of developing MRI technology with Siemens Healthcare (Erlangen, Germany).

Related Links:

Case Western Reserve University



Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Ultrasonic Pocket Doppler
SD1
Biopsy Software
Affirm® Contrast
Mobile X-Ray System
K4W

Channels

General/Advanced Imaging

view channel
CT and fused SPECT-CT images L to R of representative healthy control, pulmonary fibrosis participant & hypersensitivity pneumonitis participant (Image courtesy of SNMMI)

New SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease

Interstitial lung disease (ILD) encompasses more than 200 disorders that inflame or scar the lung interstitium and can lead to progressive respiratory failure. Determining whether active inflammation is... Read more

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.